How a person’s immune system responds to a protein called LL-37 may increase risk for developing acute coronary syndrome, but the response may also serve as a potential target for future treatments.
![](https://sciencenewsnet.in/wp-content/uploads/2024/07/1920_heart-and-veins-cedars-sinai.jpg)
news, journals and articles from all over the world.
How a person’s immune system responds to a protein called LL-37 may increase risk for developing acute coronary syndrome, but the response may also serve as a potential target for future treatments.
Paul Noble, MD, professor of Medicine at Cedars-Sinai and a leading physician-scientist in pulmonary fibrosis, recently began his one-year term as president of the highly regarded Association of American Physicians (AAP) at the group’s annual meeting in Chicago.
Ageless and evergreen: The signature lyric that sums up Robin Lipman’s reverence for one of the most iconic entertainers of our time. That epic level of fan appreciation would manifest in a fundraising campaign to benefit the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute at Cedars-Sinai.
A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography (CT) scan without contrast.
Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict sudden cardiac arrest—a health emergency that in 90% of cases leads to death within minutes.
Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology.
A new study from the Smidt Heart Institute at Cedars-Sinai shows there is a gender gap between women and men when it comes to exercise.
Experts at the Smidt Heart Institute at Cedars-Sinai who have studied progress made over decades of research say there’s still a long way to go before medical science fully understands how heart disease is different in women than men.
Cardiologists and cardiac and vascular surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews throughout February to discuss heart-related topics, including the latest advances in research and patient care.
Cardiothoracic surgeons and investigators from the Smidt Heart Institute at Cedars-Sinai will lead sessions featuring a range of heart procedures at the 60th Annual Meeting of The Society of Thoracic Surgeons (STS), Jan. 27-29, 2024, in San Antonio, Texas.
She was five days postpartum. Her first child was a perfect baby girl. What was supposed to be among the happiest times in Marisa Dominguez’s life was, instead, the scariest.
Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms.
Hispanics and Latinos with chronic kidney disease are at significant risk for suffering from sudden cardiac arrest, according to a new study from the Smidt Heart Institute at Cedars-Sinai.
A few weeks from now, Lizbeth Sanchez will say goodbye to her job in a Smidt Heart Institute laboratory and walk about 200 steps to a Cedars-Sinai classroom, where she will begin working on her doctorate in biomedical and translational research.
During National Atrial Fibrillation (AFib) Awareness Month throughout September and Aortic Disease Awareness Week, Sept.19-26, Smidt Heart Institute cardiologists and surgeons are available to speak with journalists about these common heart conditions.
The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the American Heart Association, signifying that it exceeds the highest standards of care for patients with high blood pressure—a condition that affects nearly half of all U.S. adults and increases risk for heart attack, stroke and kidney failure.
The summit is a good place to be. Staying active on the hiking trails around the southern highlands of Australia, where he retired earlier this year after a career in film marketing, Jon Anderson is feeling there’s little he can’t conquer.
Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients’ leaky mitral valves revealed the minimally invasive procedure to be safe and effective in nearly 90% of patients, according to Cedars-Sinai physician-scientists.
Investigators from the Smidt Heart Institute at Cedars-Sinai found that women who experience an adverse pregnancy outcome—such as gestational hypertension, preeclampsia or preterm birth—have a higher risk of developing stroke in their lifetime, and at a younger age.
Throughout the American Association for Thoracic Surgery (AATS) Annual Meeting, taking place May 6-9 in Los Angeles, experts from the Smidt Heart Institute at Cedars-Sinai will be available to discuss advances and innovations in cardiothoracic surgery.
Cedars-Sinai investigators, in collaboration with Axiom Space of Houston, are sending stem cells to space in early May to explore whether microgravity can make it easier and more efficient to produce large batches of stem cells.
Two Smidt Heart Institute experts have been honored for their contributions to medical research by being inducted into select medical societies, while a third expert has been selected for a leadership position.
A roundup of the latest medical discoveries and faculty news happening at Cedars-Sinai in March 2023.
Noel Bairey Merz, MD, professor of cardiology and the director of the Barbra Streisand Women’s Heart Center in the Smidt Heart Institute, will receive the 2023 Master of the ACC Award from the American College of Cardiology (ACC) in honor of her pioneering contributions to the cardiovascular profession.
Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart surgery provider, will present innovative research findings and lead discussions on the latest high-impact medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo March 4-6 in New Orleans.
Elizabeth Hinlein is freshly home from three weeks in Italy. The streets of Venice, Florence, Rome and Siena inspired her creative work as an artist and filmmaker, and also helped her regain her strength and build back her stamina. And count her lucky stars.
Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of Advanced Heart Disease and the Heart Transplant Program in the Smidt Heart Institute at Cedars-Sinai, and chief medical officer of the California Heart Center Foundation, an affiliate of Cedars-Sinai, has been selected to receive the highly coveted 2023 Lifetime Achievement Award from the International Society for Heart and Lung Transplantation (ISHLT).
Marking the five-year anniversary of the $50 million gift that named the Smidt Heart Institute, Cedars Sinai is highlighting major research breakthroughs and clinical innovations pioneered by one of the nation’s leading destinations for cardiac care.
As the nation continues to recognize American Heart Month, the Smidt Heart Institute’s Ruchira Garg, MD, director of Congenital Noninvasive Cardiology in the Guerin Family Congenital Heart Program at Cedars-Sinai, and Susanna Tran, MD, sat down with the Cedars-Sinai Newsroom to spotlight specialized fetal imaging.
Experts from the Barbra Streisand Women’s Heart Center in the Smidt Heart Institute at Cedars-Sinai are available for interviews to commemorate the 18th-annual Linda Joy Pollin Women’s Heart Health Day, Feb. 3.
Heart rhythm disorders like atrial fibrillation and sudden cardiac arrest have made headlines in recent months, prompting many to learn more about how the heart beats.
Heart disease is the leading cause of death among women in the U.S., and a type of heart attack called myocardial infarction with non-obstructive coronary arteries (MINOCA), which predominantly affects women, is garnering increased attention.
Two novel research studies from Cedars-Sinai move the needle on predicting two important heart conditions—sudden cardiac arrest, which is often fatal, and increased coronary artery calcium, a marker of coronary artery disease that can lead to a heart attack.
The Cedars-Sinai Department of Biomedical Sciences has established a new division that is charged with developing a deeper understanding of the impact of social, behavioral and environmental risk factors on human diseases.
Cardiothoracic surgeons and investigators from the Smidt Heart Institute at Cedars-Sinai bring their leading-edge expertise in heart and lung surgery to the 59th Annual Meeting of The Society of Thoracic Surgeons (STS), Jan. 21-23, 2023, in San Diego.
Martha Gulati, MD, director of Preventive Cardiology and associate director of the Preventive and Rehabilitative Cardiac Center in the Smidt Heart Institute at Cedars-Sinai, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research.
Buffalo Bills safety Damar Hamlin, 24, remains hospitalized in “critical condition” after experiencing cardiac arrest when he collapsed mid-game against the Cincinnati Bengals on Monday night.
The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of Cardiology: interventional cardiologist Aakriti Gupta, MD, electrophysiologists Eric Braunstein, MD, and Archana Ramireddy, MD, and adult congenital cardiologist Prashanth Venkatesh, MD.
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells—cells that control your heartbeat—can “fight back” against therapies to biologically correct abnormal heartbeat rates.
Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when she was surprised to hear that a cardiologist was asked to come into the exam room.
The Smidt Heart Institute at Cedars-Sinai announces the expansion of its faculty in both vascular and cardiac surgery.
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.
New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.
Martha Gulati, MD, an expert in preventive cardiology and women’s heart disease, has joined the Smidt Heart Institute as director of Preventive Cardiology, associate director of the Preventive and Rehabilitative Cardiac Center and associate director of the Barbra Streisand Women’s Heart Center in the Department of Cardiology.
A study published today in the Journal of the American College of Cardiology (JACC): Cardiovascular Imaging shows that artificial intelligence tools can more rapidly, and objectively, determine calcium scores in computed tomographic (CT) and positron emission tomographic (PET) images than physicians, even when obtained from very-low-radiation CT attenuation scans.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Today, the Food and Drug Administration (FDA) announced the approval of mavacamten, a new drug shown to provide relief to obstructive hypertrophic cardiomyopathy patients experiencing shortness of breath.
Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.